ADAMCZEWSKI Maxime
IN-DEPTH CONFERENCES
Rather than revisiting published data, invited experts are encouraged to share actionable insights, implementation strategies, and real-world experience in addressing the scientific, technological, regulatory, and financial challenges shaping the future of advanced therapies.
Through three high-level scientific sessions and a competitive plenary abstract session, Innovative Therapies Days fosters forward-looking discussions at the intersection of discovery, industrialization, and clinical deployment.
THURSDAY, OCTOBER 8TH
08:30
09:00
REGISTRATION AND WELCOME COFFEE
09:00
09:10
WELCOME ADRESS
Laurent Deschamps, PMT president & Sylvain Perruche, Temis Technopole
09:10
10:00
OPENING KEYNOTES : THE STATE OF ADVANCED THERAPIES
09:10
09:40
Standing on Shoulders, Shaping the Future: The Journey of Cell Therapies
Pierre Tiberghien, EFS & International Society of Blood Transfusion, Besançon, FRA
09:40
10:00
ATMP Landscape & Dynamics : An Overview of a Maturing Industry
Anabelle Perrier, Mabdesign, Lyon, FRA
10:00
12:15
SESSION #1 ENGINEERING THE NEXT WAVE: Beyond the First CAR-T Generations CAR-T, In Vivo Strategies, Manufacturing & Global Access
Chairpersons : Christophe Ferrand and Marina Deschamps, Right Institute, Besançon, FRA
10:00
10:30
Next-Generation CAR-T / TCR Strategies
Naomi Taylor, Center for Cancer Research, Bethesda, USA
10:30
11:15
BREAK – EXHIBITION HALL
11:15
11:45
Engineering T cells and Manufacturing multiple ATPMs: multilayered challenges and opportunities
Jean-Sébastien Delisle, Centre of excellence in cell therapy, Hôpital Maisonneuve-Rosemont and Université de Montréal, Montreal, CAN
11:45
12:15
Expanding Access to CAR-T Therapies: Middle East & Asia Perspectives
Syed Osman Ahmed, King Faisal Specialist Hospital and Research Center, Riyadh, SAU
12:15
14:00
LUNCH & EXHIBITION HALL
Simultaneous B2B meeting
14:45
17:30
SESSION #2 CAN REGENERATIVE MEDICINE BECOME INDUSTRIAL REALITY? Stem Cells : Manufacturing, Automation & the Path to Industrial Scale
Chairpersons : Mathilde Girard, Urgo Medical and Sylvain Perruche, Temis Santé, FRA
14:45
15:15
Pioneer Stem Cell Therapies: From Scientific Vision to Clinical Reality
Masayo Takahashi, VCCT Inc., Kobe, JAP
15:15
15:45
Pluripotent stem cells manufacturing for making and repairing human hearts
Robert Zweigerdt, Hannover Medical School, Hannover, GER
15:45
16:30
BREAK – EXHIBITION HALL
16:30
17:00
Pathways to Immune Tolerance: A lifelong Journey
Jeffrey Bluestone, Diabetes Center, University of California San Francisco, San Francisco, USA
17:00
17:30
Virtual Twins & AI technologies for Cell Therapy Manufacturing
Laura Guyot, Dassault Systems, Biot, FRA
17:45
18:45
OFFICIAL DELEGATION TOUR OF THE EXHIBITOR VILLAGE
17:45
22:00
POSTER'S SESSION
18:45
22:00
NETWORKING COCKTAIL – EXHIBITION HALL
FRIDAY, OCTOBER 9TH
08:15
08:30
WELCOME COFFEE
08:30
09:00
OPENING KEYNOTES
08:30
09:00
ATMP Development Support: Lessons from the ANSM Guidance Office
Guillaume Vaquer, French National Agency for Medicines and Health Products Safety, Paris, FRA
09:00
12:15
SESSION #3 WHAT COMES AFTER CELLS? Extracellular Vesicles, Cell-Free Therapies & Enabling Technologies
Chairpersons : Jérémy Magalon, AP-HM and Céline Elie-Caille, Femto-ST, FRA
09:00
09:30
Clinical Potential of MSC-EVs and Translational Challenges
Bernd Giebel, University of Duisburg-Essen, Essen, GER
09:30
10:00
Fibrinolytic Extracellular Vesicles: From Biology to a New Class of Thrombolytic Agents
Romaric Lacroix, AMU & Inserm 1263, Aix-Marseille, FRA
10:00
10:45
BREAK – EXHIBITION HALL
10:45
11:15
Engineering Extracellular Vesicles for RNA Therapeutic Delivery
Florence Gazeau, NABI lab, Paris, FRA
11:15
11:45
Regulatory Status of EVs in Europe
Mathieu Guerriaud, CREDIMI University of Burgundy, Dijon, FRA
11:45
12:15
Microtechnologies Enabling Advanced Therapies
Maxime Adamczewski, BioIMP consortium, Besançon, FRA
12:15
14:00
LUNCH & Exhibition Hall
Simultaneous B2B meeting
14:00
15:30
SESSION #4 Emerging Innovations in Advanced Therapies
Chairpersons : Olivier Humbey, IQVIA and Agnès Fourcot, PMT, FRA
14:00
AImCell: A Live Imaging Non-invasive Machine Learning Approach for Cell Differentiation Monitoring and Non-compliant Batch Prediction
Yana Ragozina, Dassault Systèmes, Valbonne, FRA
14:15
A novel, highly melanoma-specific TCR-T cell product demonstrates safe and enhanced responses against several melanoma models
Thibault C. Leray, Oslo University Hospital., Oslo, NOR
14:30
CAR123-IL-21 NK Cell Platform: Construct optimization and Preliminary NK-92 Study
Jean-Francis Berry, Right Institute, Besançon, FRA
14:45
Validation of a Cyopreservation Strategy of Adipose Tissue for Therapeutic Use
Soha Karnib, AP-HM, Marseille, FRA
15:00
Fully closed automated CAR-T cells culture system including real-time and sampling-less quality controls: a first demonstrator
Charles-Louis Azzopardi, Marie et Louis Pasteur University, CNRS, FEMTO-ST Institute, Besançon, FRA
15:15
Matrix-based risk analysis approach to determine the location of surface environmental monitoring in cleanrooms
Jimmy Lagarde, Montpellier University, Montpellier, FRA
15:30
15:45
AWARDS & CLOSING REMARKS
Award of the prize for the best presentation and draw of the contest.
